Tci Wealth Advisors, Inc. Protagonist Therapeutics, Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$10.78 - $25.38 $1,390 - $3,274	129 New	129 $2,000
Q3 2022 Nov 08, 2022	BUY	$7.86 - $11.71 $3,041 - $4,531	387 New	387 $3,000
Q1 2022 Apr 29, 2022	SELL	$23.34 - $36.08 $5,111 - $7,901	-219 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$17.63 - $37.1 $1,286 - $2,708	73 Added 50.0%	219 $7,000
Q3 2021 Oct 29, 2021	BUY	$12.95 - $49.69 $660 - $2,534	51 Added 53.68%	146 $3,000
Q2 2021 Aug 02, 2021	BUY	$25.57 - $44.88 $818 - $1,436	32 Added 50.79%	95 $4,000
Q1 2021 Apr 29, 2021	BUY	$19.02 - $31.15 $1,198 - $1,962	63 New	63 $2,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.